Skip to main content
AMNAMN Healthcare Services IncSell6.1·$32.01-3.73%
SellModerate Confidence
Investment thesis

AMN's exceptional revenue growth and solid recent earnings execution stand out, but a quality score below the required threshold, overbought momentum, and bearish insider selling warrant caution.

Thesis pillars

  • Industry Leading Revenue GrowthStable
  • Quality Below Required FloorStable
  • Overbought Momentum ConditionStable
  • +2 more pillars — see the Why tab for full reasoning

Full reasoning →

Open full analysis

AMN Healthcare Services Inc (AMN) Stock Analysis

Range Bound setup

SellValueGrowthModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Engine safety override at $32.01: Quality below floor (2.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.1/10. Specifically: Elevated put/call ratio: 2.42; Below-average business quality.

AMN Healthcare Services is a leading provider of total talent solutions for the U.S. healthcare sector, offering nurse/physician/allied-health staffing, managed services programs, vendor management systems, language interpretation, and workforce technology like its WorkWise... Read more

$32.01+10.8% A.UpsideScore 6.1/10#9 of 36 Medical Care Facilities
QualityF-score5 / 9FCF yield48.40%
Stop $29.83Target $35.54(resistance)A.R:R -1.8:1
Analyst target$29.86-6.7%7 analysts
$35.54our TP
$32.01price
$29.86mean
$22
$38

Sell if holding. Engine safety override at $32.01: Quality below floor (2.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.1/10. Specifically: Elevated put/call ratio: 2.42; Below-average business quality. Chart setup: RSI 51 mid-range, Bollinger mid-band. Score 6.1/10, moderate confidence.

Passes 6/9 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 30d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Aug 6, 202630d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Target reached (-19.0% upside)
Quality below floor (2.7 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)32.9
Mkt Cap$1.4B
EV/EBITDA5.5
Profit Mgn-0.9%
ROE-4.5%
Rev Growth99.9%
Beta0.41
DividendNone
Rating analysts13

Quality Signals

Piotroski F5/9

Options Flow

P/C2.42bearish
IV89%elevated
Max Pain$20-37.5% vs spot

Concentration Risks(10-K Item 1A)

  • LOWCustomerKaiser Foundation Hospitals22%
    10-K Item 1A: 'Kaiser Foundation Hospitals (and its affiliates) (collectively, “Kaiser”) comprised approximately 22% of our consolidated revenue in 2025.'

Material Events(8-K, last 90d)

  • 2026-05-04Item 5.02LOW
    Shareholders approved Amendment No. 1 to the AMN Healthcare 2025 Equity Plan at the May 1, 2026 Annual Meeting, previously approved by the Board subject to shareholder vote. Routine compensatory plan item; no officer or director departure involved.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker·1 ceiling hit

Unprofitable operations — net margin -0.9%. Quality floor flags this regardless of sector context.static

Roe
0.0
Net Margin
0.0
Gross Margin
1.5
Roa
2.3
Operating Margin
3.4
Moat
4.2
Current Ratio
4.3
Piotroski F
5.6
No competitive moatQuality concerns
GatesA.R:R -1.8=NEGATIVEMomentum 4.8<5.5 (soft — BUY_NOW allowed but watch)Executive change: officer departure/appointmentMomentum 4.8>=4.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 30d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
51 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $29.28Resistance $36.27

Price Targets

$30
$36
A.Upside+11.0%
A.R:R-1.8:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-19.0% upside)
! Quality below floor (2.7 < 4.0)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-08-06 (30d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AMN stock a buy right now?

Sell if holding. Engine safety override at $32.01: Quality below floor (2.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.1/10. Specifically: Elevated put/call ratio: 2.42; Below-average business quality. Chart setup: RSI 51 mid-range, Bollinger mid-band. Prior stop was $29.83. Score 6.1/10, moderate confidence.

What is the AMN stock price target?

Take-profit target: $35.54 (+10.8% upside). Prior stop was $29.83. Stop-loss: $29.83.

What are the risks of investing in AMN?

Target reached (-19.0% upside); Quality below floor (2.7 < 4.0).

Is AMN overvalued or undervalued?

AMN Healthcare Services Inc trades at a P/E of N/A (forward 32.9). TrendMatrix value score: 7.0/10. Verdict: Sell.

What do analysts say about AMN?

13 analysts cover AMN with a consensus score of 3.5/5. Average price target: $30.

What does AMN Healthcare Services Inc do?AMN Healthcare Services is a leading provider of total talent solutions for the U.S. healthcare sector, offering...

AMN Healthcare Services is a leading provider of total talent solutions for the U.S. healthcare sector, offering nurse/physician/allied-health staffing, managed services programs, vendor management systems, language interpretation, and workforce technology like its WorkWise platform and AMN Passport app (340,000+ users). The company had 2,664 corporate team members as of December 31, 2025 and averaged about 8,722 nurses/allied professionals in Q4 2025, with Kaiser Foundation Hospitals its largest client at approximately 22% of 2025 consolidated revenue.

Related stocks: NUTX (Nutex Health Inc.) · SRTA (Strata Critical Medical, Inc.) · TOI (The Oncology Institute, Inc.) · ARDT (Ardent Health, Inc.) · EHC (Encompass Health Corporation)
Home Stocks AMN

Latest news

No recent news